Follow WOWNEWS 24x7 on:
Zydus Lifesciences received an EIR from the USFDA for its Jarod injectable facility after a GMP inspection concluded with a Voluntary Action Indicated (VAI) classification. The outcome, following a prior warning letter, strengthens Zydus’s compliance standing and supports its injectable product supply to the US market.
Show moreStay Ahead – Explore Now! Brookfield Asset Management to buy Colonial Pipeline in $9 billion deal, sources say
Follow WOWNEWS 24x7 on:
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
